
Faster Biological Aging May Help Explain Why More Younger Adults Are Getting Cancer
Younger generations are now aging faster than their parents and grandparents, and this aging gap could explain the rise in early-onset cancers.

Younger generations are now aging faster than their parents and grandparents, and this aging gap could explain the rise in early-onset cancers.

A tiny silk sticker that visibly shows vital health signals, read by an AI system, could change how we care for the tiniest patients

One paper by Dr. Stuart Turvey and colleagues at BC Children’s Hospital Research Institute (BCCHR) and another paper by Dr. Marie-Claire Arrieta and colleagues from the Snyder Institute for Chronic Diseases and the Alberta Children’s Hospital Research Institute reveal key to treating asthma.

In a study from Karolinska Institutet, the Stockholm3 blood test detected more clinically significant cancer cases than the PSA test, without subjecting more men to unnecessary testing.

Researchers have now found a way to turn this emergency into a tool to protect the body from the devastating effects of another health emergency—a stroke.

In partnership with Gemini Untwined, XRlabs’ Surgical Intelligence platform generated custom implants in seconds and enabled successful craniopagus twin separation

Spiraling waves of neural activity appear and travel in the brain. Scientists hope to learn if these rotating waves on the move play a global role in sensing and interpreting internal and external stimuli, in laying down memory and in managing motor performance.

Researchers at the Federal University of São Paulo (UNIFESP) in Brazil have identified a molecule on the surface of cells that could be a promising therapeutic target against cancer.

A new study from RCSI University of Medicine and Health Sciences demonstrates a novel approach in anticancer vaccine development. The results, published in Molecular Therapy Oncology, present the first preclinical evidence showing the efficacy of an mRNA vaccine in targeting neuroblastoma, the deadliest childhood cancer.

Now, a study published in Science Translational Medicine offers a new strategy capable of identifying chemical compounds that could be further developed into antibiotic therapies with high selectivity for N. gonorrhoeae.